J P Seale|P J Piper - JoVE Visualize

Showing results (161-170 of 187) with videos related to

Pageof 19

Sort By:

British Journal of Clinical Pharmacology|December 1, 1990

Leukotrienes in the sputum and urine of cystic fibrosis childrenA P Sampson, D A Spencer, C P Green, et al.

Addiction (Abingdon, England)|May 15, 1998

An evaluation of two primary care interventions for alcohol abuse among Mexican-American patientsS K Burge, N Amodei, B Elkin, et al.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 1, 1990

Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal manD A Spencer, S E Green, J M Evans, et al.

Journal of the American College of Cardiology|July 21, 1998

Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosisM R Adams, J Robinson, R McCredie, et al.

FEBS Letters|October 1, 1984

PHI-like immunoreactivity in the gallbladder and in vitro effect of porcine PHI on smooth muscle of the gallbladderY Yiangou, N D Christofides, J Gu, et al.

Circulation|July 1, 1994

Preferential vasoconstriction to cysteinyl leukotrienes in the human saphenous vein compared with the internal mammary artery. Implications for graft performanceS P Allen, A H Chester, M R Dashwood, et al.

Archives of Disease in Childhood|March 1, 1993

Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosisP Greally, M J Hussein, A J Cook, et al.

Global Public Health|April 7, 2025

Motivations, expectations, and hopes of participants and stakeholders in the GROW 'Hopes for Life' intervention studyM Mulavu, S K Harris, J P Seale, et al.

British Journal of Clinical Pharmacology|November 1, 1992

Effects of leukotrienes C4 and D4 on human isolated saphenous veinsS P Allen, A H Chester, P J Piper, et al.

Coronary Artery Disease|October 1, 1993

Enhanced excretion of urinary leukotriene E4 in coronary artery disease and after coronary artery bypass surgeryS P Allen, A P Sampson, P J Piper, et al.

Pageof 19

Showing results (161-170 of 187) with videos related to

Sort By:

Pageof 19

British Journal of Clinical Pharmacology|December 1, 1990

Leukotrienes in the sputum and urine of cystic fibrosis childrenA P Sampson, D A Spencer, C P Green, et al.

Addiction (Abingdon, England)|May 15, 1998

An evaluation of two primary care interventions for alcohol abuse among Mexican-American patientsS K Burge, N Amodei, B Elkin, et al.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 1, 1990

Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal manD A Spencer, S E Green, J M Evans, et al.

Journal of the American College of Cardiology|July 21, 1998

Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosisM R Adams, J Robinson, R McCredie, et al.

FEBS Letters|October 1, 1984

PHI-like immunoreactivity in the gallbladder and in vitro effect of porcine PHI on smooth muscle of the gallbladderY Yiangou, N D Christofides, J Gu, et al.

Circulation|July 1, 1994

Preferential vasoconstriction to cysteinyl leukotrienes in the human saphenous vein compared with the internal mammary artery. Implications for graft performanceS P Allen, A H Chester, M R Dashwood, et al.

Archives of Disease in Childhood|March 1, 1993

Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosisP Greally, M J Hussein, A J Cook, et al.

Global Public Health|April 7, 2025

Motivations, expectations, and hopes of participants and stakeholders in the GROW 'Hopes for Life' intervention studyM Mulavu, S K Harris, J P Seale, et al.

British Journal of Clinical Pharmacology|November 1, 1992

Effects of leukotrienes C4 and D4 on human isolated saphenous veinsS P Allen, A H Chester, P J Piper, et al.

Coronary Artery Disease|October 1, 1993

Enhanced excretion of urinary leukotriene E4 in coronary artery disease and after coronary artery bypass surgeryS P Allen, A P Sampson, P J Piper, et al.

Pageof 19